Characteristics and Outcomes of Heart Failure Patients from a Middle-Income Country: The RECOLFACA Registry
By: Juan Esteban Gomez-Mesa, Clara Saldarriaga, Luis Eduardo Echeverría, Alex Rivera-Toquica, Paula Luna, Sebastián Campbell, Lisbeth Natalia Morales, Juan David López Ponce de León, Andrés Felipe Buitrago, Erika Martínez, Jorge Alberto Sandoval, Alexis Llamas, Gustavo Adolfo Moreno, Julián Vanegas and Fernán Mendoza Beltrán
References
- Ciapponi A, Alcaraz A, Calderón M, Matta MG, Chaparro M, Soto N, et al. Carga de enfermedad de la insuficiencia cardiaca en América Latina: Revisión sistemática y metanálisis. Revista Espanola de Cardiologia. 2016; 69(11): 1051–1060. DOI: 10.1016/j.recesp.2016.04.045
- Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries. JACA. 2014; 63(12): 1123–1133. DOI: 10.1016/j.jacc.2013.11.053
- Taylor CJ, Ryan R, Nichols L, Gale N, Hobbs FR, Marshall T. Survival following a diagnosis of heart failure in primary care. Family practice. 2017; 34(2): 161–168. DOI: 10.1093/fampra/cmw145
- Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W, et al. Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): A cohort study. Lancet Glob Health. 2020; 8(8):
e1001 . DOI: 10.1016/S2214-109X(20)30294-1 - Olivera MJ, Fory JA, Porras JF, Buitrago G. Prevalence of Chagas disease in Colombia: A systematic review and meta-analysis. PloS one. 2019; 14(1):
e0210156-e . DOI: 10.1371/journal.pone.0210156 - Instituto Nacional de Salud, Observatorio Nacional de Salud. Acceso a servicios de salud en Colombia: Décimo primer Informe Técnico. Acceso a servicios de salud en Colombia; 2019. (accessed 3 June 2022).
- Montenegro Torres F, Bernal Acevedo O. Colombia case study: The subsidized regime of Colombia’s national health insurance system. UNICO Studies Series. 2013; p. 15.
https://openknowledge.worldbank.org/handle/10986/13285 (accessed 1 June 2022). - Colombia MdSyPS. Cifras de aseguramiento en salud. Mibisterio de Salud; 2021.
https://www.minsalud.gov.co/proteccionsocial/Paginas/cifras-aseguramiento-salud.aspx . - Garcíai JA. La salud en Colombia: Más cobertura pero menos acceso. Documentos de Trabajo Sobre Economía Regional. 2014; p. 204. (accessed 3 June 2022).
- Colombia MdSyPS. Servicios y tecnologías de salud financiados con recursos de la Unidad por Pago por Capitación (UPC). Resolución Número 2292. Ministerio de Salud; 2021.
https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%20No.%202292%20de%202021.pdf . - Diaztagle-Fernández JJ, Latorre-Alfonso SI, Maldonado-Arenas SE, Manosalva-Álvarez GP, Merchán-Cepeda JS, Centeno-García CD, et al. Research on heart failure in Colombia 1980–2015: A systematic review. Revista Facultad de Medicina. 2018; 66(2): 139–351. DOI: 10.15446/revfacmed.v66n2.60005
- Mora-Pabón G. Research on heart failure in Colombia, time to take a step forward. Revista Facultad de Medicina. 2018; 66(2): 137–138. DOI: 10.15446/revfacmed.v66n2.70828
- EuroQol Research Foundation. EQ-5D-3L user guide.
https://euroqol.org/publications/user-guides2018 . - The R Foundation.
The R project for statistical computing . Vienna; 2020. - Garcia-Ramirez J, Nikoloski Z, Mossialos E. Inequality in healthcare use among older people in Colombia. International Journal for Equity in Health. 2020; 19(1): 168. DOI: 10.1186/s12939-020-01241-0
- Pandey A, Omar W, Ayers C, LaMonte M, Klein L, Allen NB, et al. Sex and race differences in lifetime risk of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Circulation. 2018; 137(17): 1814–1823. DOI: 10.1161/CIRCULATIONAHA.117.031622
- Bocchi EA, Arias A, Verdejo H, Diez M. The reality of heart failure in Latin America. 2013; 62(11). DOI: 10.1016/j.jacc.2013.06.013
- Echeverría LE, Marcus R, Novick G, Sosa-Estani S, Ralston K, Zaidel EJ, et al. WHF IASC roadmap on Chagas disease. Glob Heart. 2020; 15(1): 26. DOI: 10.5334/gh.484
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016; 18(8): 891–975. DOI: 10.1002/ejhf.592
- Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ,
Jr. , Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992; 327(10): 669–677. DOI: 10.1056/NEJM199209033271001 - The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine. 1992; 327(10): 685–691. DOI: 10.1056/NEJM199209033271003
- Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: A follow-up study. Lancet. 2003; 361(9372): 1843–1848. DOI: 10.1016/S0140-6736(03)13501-5
- McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. New England Journal of Medicine. 2014; 371(11): 993–1004. DOI: 10.1056/NEJMoa1409077
- Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, et al. EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). European Journal of Heart Failure. 2013; 15(7): 808–817. DOI: 10.1093/eurjhf/hft050
- Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L, Mangues MA, Bayes-Genis A. Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: Impact of a pharmacist in a multidisciplinary HF clinic. Journal of Cardiac Failure. 2011; 17(3): 217–223. DOI: 10.1016/j.cardfail.2010.10.009
- Wiggins BS, Rodgers JE, DiDomenico RJ, Cook AM, Page
II RL. Discharge counseling for patients with heart failure or myocardial infarction: A best practices model developed by members of the American College of Clinical Pharmacy’s Cardiology Practice and Research Network based on the Hospital to Home (H2H) Initiative. Pharmacotherapy. 2013; 33(5): 558–580. DOI: 10.1002/phar.1231 - van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: Changes from 2004 to 2008. Eur J Heart Fail. 2009; 11(12): 1143–1151. DOI: 10.1093/eurjhf/hfp149
- Ministerio de Salud y Protección Social, Colombia. Listado Actualización Integral 2020–2021; 2021.
DOI: https://doi.org/10.5334/gh.1145 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jan 17, 2022
Accepted on: Jul 26, 2022
Published on: Aug 18, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2022 Juan Esteban Gomez-Mesa, Clara Saldarriaga, Luis Eduardo Echeverría, Alex Rivera-Toquica, Paula Luna, Sebastián Campbell, Lisbeth Natalia Morales, Juan David López Ponce de León, Andrés Felipe Buitrago, Erika Martínez, Jorge Alberto Sandoval, Alexis Llamas, Gustavo Adolfo Moreno, Julián Vanegas, Fernán Mendoza Beltrán, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.